Dr Reddys Laboratories Income Statement (2009-2026) | RDY

Income Statement Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Mar2022 Jun2022 Dec2022 Mar2023 Jun2023 Mar2024 Mar2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.52B0.67B0.61B0.60B0.67B0.68B0.66B0.78B0.77B0.81B0.83B
Cost of Revenue (Quarter)
0.23B0.29B0.28B0.26B0.31B0.31B0.32B0.36B0.33B0.34B0.34B
Gross Profit (Quarter)
0.29B0.39B0.33B0.34B0.36B0.36B0.35B0.41B0.44B0.48B0.49B
Operating items
Amortization - Intangibles (Quarter)
Depreciation & Amortization - Total (Quarter)
Research & Development (Quarter)
0.06B0.05B0.06B0.05B0.06B0.06B0.06B0.06B0.07B0.06B0.07B
Selling, General & Administrative (Quarter)
0.17B0.18B0.18B0.17B0.18B0.20B0.20B0.21B0.22B0.21B0.23B
Other Operating Expenses (Quarter)
-0.00B-0.01B-0.00B-0.00B-0.00B-0.01B-0.02B-0.00B-0.01B-0.02B
Operating Expenses (Quarter)
0.23B0.24B0.23B0.23B0.24B0.25B0.26B0.28B0.28B0.27B0.29B
Operating Income (Quarter)
0.07B0.10B-0.08B0.11B0.11B-0.08B0.09B0.16B0.15B0.21B0.21B
EBIT (Quarter)
0.07B0.10B-0.08B0.11B0.11B-0.08B0.09B0.16B0.15B0.21B0.21B
Non-operating items
Interest & Investment Income (Quarter)
-0.00B-0.01B
Other Non Operating Income (Quarter)
-0.01B
Non Operating Income (Quarter)
-0.01B-0.01B-0.00B-0.01B-0.01B-0.00B-0.01B-0.01B-0.01B
Net income details
EBT (Quarter)
0.08B0.11B0.08B0.12B0.12B-0.07B0.10B0.17B0.16B0.22B0.23B
Tax Provisions (Quarter)
0.01B-0.05B0.01B0.02B0.04B0.04B0.05B0.06B
Profit After Tax (Quarter)
0.07B0.15B0.07B0.12B0.10B-0.08B0.08B0.13B0.12B0.17B0.17B
Income from Continuing Operations (Quarter)
0.07B0.15B0.07B0.12B0.12B-0.07B0.08B0.13B0.12B0.17B0.17B
Income from Discontinued Operations (Quarter)
0.04B0.01B0.04B
Consolidated Net Income (Quarter)
0.07B0.15B0.07B0.16B0.13B-0.04B0.08B0.13B0.12B0.17B0.17B
Income towards Parent Company (Quarter)
0.07B0.15B-0.08B0.08B0.15B-0.04B0.08B0.13B0.12B0.17B0.18B
Net Income towards Common Stockholders (Quarter)
0.07B0.15B-0.08B0.08B0.15B-0.04B0.08B0.13B0.12B0.17B0.18B
Additional items
EPS (Basic) (Quarter)
0.220.18-0.100.100.18-0.040.090.160.140.200.21
EPS (Diluted) (Quarter)
0.080.18-0.100.100.18-0.040.090.160.140.200.21
Shares Outstanding (Quarter)
0.31B0.75B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B
Shares Outstanding (Diluted) (Quarter)
0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B0.83B
EBITDA (Quarter)
0.07B0.10B-0.08B0.11B0.11B-0.08B0.09B0.16B0.15B0.21B0.21B
Interest Expenses (Quarter)
Tax Rate (Quarter)
17.50%-42.99%16.05%23.00%21.64%27.78%23.87%26.09%